SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-018873
Filing Date
2017-03-23
Accepted
2017-03-23 17:00:48
Documents
3
Effectiveness Date
2017-03-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-8680_2defa14a.htm DEFA14A 8346
2 GRAPHIC g86802bai001.gif GRAPHIC 124812
3 GRAPHIC g86802bai002.gif GRAPHIC 101884
  Complete submission text file 0001104659-17-018873.txt   321683
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37691 | Film No.: 17710319
SIC: 2834 Pharmaceutical Preparations